| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Sale+OE | 19,442 | $7.04 | $136,871.68 | -100% | -51.3% | - | |
| Dec 17, 2025 | Shlevin Harold H.89 | Director | Sale+OE | 24,499 | $7.04 | $172,423.96 | -58.0% | -51.3% | - | |
| Dec 17, 2025 | Lewis Joel59 | President And CEO | Sale+OE | 7,829 | $7.06 | $55,241.42 | -0.9% | -51.3% | - | |
| Dec 16, 2025 | 10x Fund, L.P.85 | 10% Owner | Sell | 30,681 | $6.66 | $204,335.46 | -0.5% | -48.7% | - | |
| Dec 15, 2025 | Shlevin Harold H.89 | Director | Sale+OE | 28,210 | $6.28 | $177,208.38 | -55.7% | -51.2% | - | |
| Dec 9, 2025 | Shlevin Harold H.89 | Director | Sale+OE | 175,790 | $6.00 | $1,055,311.14 | -66.2% | -43.7% | - | |
| Dec 3, 2025 | 10x Fund, L.P.85 | 10% Owner | Sell | 150,000 | $5.68 | $851,700.00 | -1.3% | -47.7% | - | |
| Nov 18, 2025 | Lewis Joel59 | President And CEO | Sale+OE | 22,463 | $6.07 | $136,365.82 | -1.3% | -55.7% | - | |
| Nov 18, 2025 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 77,920 | $6.15 | $478,849.17 | -67.2% | -55.7% | - | |
| Nov 13, 2025 | Jamil Khurram | Chief Medical Officer | Sale+OE | 121,117 | $5.47 | $662,509.99 | -87.1% | -50.1% | - |